All News

CAR-X

BioCentriq® Unveils LEAP™ Advanced Therapy Platform, Enabling Rapid Patient Access for Early-Stage Biotech Companies
5 June 2023
BioCentriq® Unveils LEAP™ Advanced Therapy Platform, Enabling Rapid Patient Access for Early-Stage Biotech Companies
BioCentriq launched their new LEAP™
Nexcella Initiates NXC-201 Engineering Batches at its U.S. CAR-T Manufacturing Facility
2 June 2023
Nexcella Initiates NXC-201 Engineering Batches at its U.S. CAR-T Manufacturing Facility
Nexcella, a subsidiary of Immix
CDMO, uBriGene, Expands to the US Market with Major Acquisition
19 May 2023
CDMO, uBriGene, Expands to the US Market with Major Acquisition
CDMO, uBriGene, Expands to the
Oxford Biomedica Launches Next Generation Lentiviral Vector System: TetraVecta™
18 May 2023
Oxford Biomedica Launches Next Generation Lentiviral Vector System: TetraVecta™
Oxford Biomedica launches TetraVecta™
POPULAR NEWS ITEMS
Image
8 June 2023

Eureka Therapeutics Awarded $10.6M CIRM Grant for T-Cell Therapy in Pediatric Liver Cancer

Image
7 June 2023

Cell and Gene Therapy Catapult Open New Edinburgh, UK, Facilities

Image
5 June 2023

BioCentriq® Unveils LEAP™ Advanced Therapy Platform, Enabling Rapid Patient Access for Early-Stage Biotech Companies

Bristol Myers Squibb’s CAR-T Breyanzi Receives Recommendation for Approval from EMA’s CHMP
4 April 2023
Bristol Myers Squibb’s CAR-T Breyanzi Receives Recommendation for Approval from EMA’s CHMP
Bristol Myers Squibb’s CAR-T Breyanzi
Cabaletta Bio to Commence Trial of CABA-201 for Lupus Treatment After FDA Clearance
4 April 2023
Cabaletta Bio to Commence Trial of CABA-201 for Lupus Treatment After FDA Clearance
Cabaletta Bio, a clinical-stage biotechnology
Sartorius to Acquire Polyplus in a $2.6 Billion Cell and Gene Therapy Expansion
3 April 2023
Sartorius to Acquire Polyplus in a $2.6 Billion Cell and Gene Therapy Expansion
Sartorius to Acquire Polyplus in
Sonoma Biotherapeutics and Regeneron Announce $120M Collaboration for Cell Therapies for Autoimmune Diseases
30 March 2023
Sonoma Biotherapeutics and Regeneron Announce $120M Collaboration for Cell Therapies for Autoimmune Diseases
Clinical-stage biotech company Sonama Biotherapeutics
Load more News
RECOMENDED TOPICS
Allogeneic
Autologous
CAR-X
Cell Therapy
Cell-Based IO
Gene Editing
Gene Therapy
NKx
Stem Cells
Tissue Engineering
Viral/Non-Viral Vectors
POPULAR NEWS ITEMS
Image

Eureka Therapeutics Awarded $10.6M CIRM Grant for T-Cell Therapy in Pediatric Liver Cancer

Image

Cell and Gene Therapy Catapult Open New Edinburgh, UK, Facilities

Image

BioCentriq® Unveils LEAP™ Advanced Therapy Platform, Enabling Rapid Patient Access for Early-Stage Biotech Companies